ACTIVATION OF DEATH PATHWAYS IN CHEMOREFRACTORY PROSTATE CANCER STEM CELLS BY INHIBITION OF SLEEPER KINASES

H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.

Investigators